BD collaborates with the federal and Quebec provincial government to support the COVID-19 pandemic
BD (Becton, Dickinson and Company) is committed to supporting health care systems across Canada in response to the COVID-19 pandemic by supplying critical technologies, such as diagnostic tools and injection devices.
In collaboration with the federal government, BD has recently received a large pandemic order to produce 37.6 million vaccine injection devices to support Canada in planning for a COVID-19 vaccination campaign.
The organization has also collaborated with Quebec Public Health and the provincial Ministry of Health to source a loaner testing unit to expedite COVID-19 testing in Quebec. With the fully integrated, BD MAX™ diagnostic testing system now on-site, clinicians at the Gatineau Public Health Labs can process patient swabs and diagnose cases of COVID-19 locally, within 2–3 hours of taking the sample. The lab previously had a capability of 50 tests per week, which has now increased to 1,400 per week.
